MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $96,000 | -74.4% | 17,755 | -60.4% | 0.00% | -100.0% |
| Q1 2016 | $375,000 | +341.2% | 44,820 | +316.0% | 0.00% | +100.0% |
| Q4 2015 | $85,000 | -86.2% | 10,774 | -85.2% | 0.00% | -75.0% |
| Q3 2015 | $618,000 | +39.2% | 72,591 | +102.2% | 0.00% | +33.3% |
| Q2 2015 | $444,000 | +114.5% | 35,895 | +105.5% | 0.00% | +50.0% |
| Q1 2015 | $207,000 | -92.7% | 17,463 | -94.6% | 0.00% | -93.1% |
| Q3 2014 | $2,829,000 | +1489.3% | 322,161 | +810.3% | 0.03% | +1350.0% |
| Q1 2014 | $178,000 | – | 35,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |